Digoxin vs Osimertinib
Digoxin vs Osimertinib: Overview
This comparison examines the pharmacological differences between Digoxin and Osimertinib.
Mechanism of Action
Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Digoxin β 36-48 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Digoxin β C41H64O14; Osimertinib β C28H33N7O2.
Molecular Weight: Digoxin β 780.9430 g/mol; Osimertinib β 499.6050 g/mol.
Type: Digoxin β Small molecule; Osimertinib β Small molecule.